CV Lattes
Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. Escola Paulista de Medicina (EPM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Has experience in Medicine, acting on the following subjects: acute myelogenous leukemia, cell death and syzygium jambolanum. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The treatment used in acute myelogenous leukemia (AML) therapy involves the combination of cytarabine / idarubicin or daunorubinin. This treatment achieves a cure rate of 35-40% in patients less than 60 years of age, and 5-15% in older patients, since many individuals recur in a short time, which often results in low cure percentages. In this context, research involving strategies to impr…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |